news
Sickle cell drugs could be tested with help from new computer model
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
List view / Grid view
Technology
news
New model predicts cognitive decline two years ahead
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
news
New medicinal advances could be yielded by studying proteins in glass
A unique method for studying proteins has been developed which could open new doors for medicinal research.
product
Video: Cubis® II Balance
13 June 2019 | By Sartorius AG
The new generation of modular premium laboratory balances.
news
High-res 3D structure of proteins inside living eukaryotic cells determined
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
news
UK drug discovery market ‘thriving’ says new report
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.
news
Gene editing tools market valued at $258 million in 2018
The global gene editing tools market is estimated to have accounted for more than US$258 million in terms of value in 2018.
article
AI-driven automated chemistry as a tool to accelerate drug discovery
Typically, early drug discovery campaigns start with the screening of chemical libraries to identify candidate chemotypes modulating a particular target and/or phenotype. Success of the primary screening depends on multiple factors related to both biology and chemistry. These include the target’s druggability, sensitivity and specificity of assay system, composition and…
news
Innovative mechanobiology research expands understanding of cells
Researchers have developed a new technology that allows them to probe cell changes without disturbing the cell’s physiology.
news
Magnetic microbots could help drug-delivery nanoparticles reach their targets
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumour or another disease site.
news
New information on the pathological mechanisms of Alzheimer’s disease
Researchers have indicated that the accumulation of pathological tau triggers a safety valve mechanism in the otherwise well-regulated cell membranes...
news
Charles River and Distributed Bio enter exclusive partnership to create an integrated antibody discovery and development platform
Charles River Laboratories International, Inc. announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimisation of antibody discovery platforms...
article
Synthetic biology in drug discovery
Synthetic biology is broadly defined as the design and construction of novel artificial biological pathways, organisms or devices; or the redesign of existing natural biological systems.1 It brings together a range of disciplines and skills, from biology and chemistry to computing, bioinformatics and engineering.
news
The European Antibody Congress is returning to the city of Basel
The European Antibody Congress is returning to the city of Basel for its 14th year on the 29-31 October 2018, and here is everything you need to know about our biggest event yet...
